Mirati Therapeutics shares owned by Paradigm Biocapital Advisors
Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Paradigm Biocapital Advisors
from 13F filings
Historical chart of Paradigm Biocapital Advisors investment in Mirati Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Mirati Therapeutics held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Mirati Therapeutics by Paradigm Biocapital Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $91M | 1.5M | 58.75 |
2023-09-30 | $73M | 1.7M | 43.56 |
2023-06-30 | $52M | 1.4M | 36.13 |
2023-03-31 | $52M | 1.4M | 37.18 |
2022-12-31 | $58M | 1.3M | 45.31 |
2022-09-30 | $59M | 850k | 69.84 |
2022-06-30 | $44M | 660k | 67.13 |
2022-03-31 | $8.1M | 98k | 82.22 |
2021-12-31 | $38M | 260k | 146.69 |
More positions owned by Paradigm Biocapital Advisors
View all positions for Paradigm Biocapital Advisors